Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CSTL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CSTL investment potential.

What is CSTL stock price today?

Get real-time CSTL stock price, historical data, and price charts on Financhill. Track CSTL performance with our advanced analysis tools.

Is CSTL a good investment?

Evaluate CSTL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CSTL stock?

To buy CSTL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CSTL?

View detailed market capitalization data and company valuation metrics for CSTL on our comprehensive analysis page.

What is the P/E ratio of CSTL?

Use our fundamental analysis tools to view CSTL P/E ratio and compare valuation metrics with industry peers.

What are CSTL earnings?

View CSTL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Castle Biosciences, Inc. 10K Form

Buy

CSTL
Castle Biosciences, Inc.

Last Price:

$38.41

Seasonality Move:

21.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-09	10Q	CSTL/Castle Biosciences, Inc. Quarterly
2020-08-10	10Q	CSTL/Castle Biosciences, Inc. Quarterly
2020-05-11	10Q	CSTL/Castle Biosciences, Inc. Quarterly
2020-03-10	10K	CSTL/Castle Biosciences, Inc. Annual
2019-11-12	10Q	CSTL/Castle Biosciences, Inc. Quarterly
2019-09-03	10Q	CSTL/Castle Biosciences, Inc. Quarterly

Receive CSTL News And Ratings

See the #1 stock for the next 7 days that we like better than CSTL

CSTL Financial Statistics

Sales & Book Value

Annual Sales:	$332.1M
Cash Flow:	$7.8M
Price / Cash Flow:	35.38
Annual Sales:	$16.02
Price / Book:	2.41

Profitability

EPS (TTM):	-0.45000
Net Income (TTM):	$-12.2M
Gross Margin:	$258.8M
Return on Equity:	-2.71%
Return on Assets:	-2.29%

Castle Biosciences, Inc. Earnings Forecast

Key Castle Biosciences, Inc. Financial Ratios

The Gross Profit Margin over the past 8 years for CSTL is 77.94%.
The Selling, General & Administrative Expenses for CSTL have been equal to 60.24% of Gross Profit Margin.
The Research & Development expenses have been 15.57% of Revenue.
The Interest Expense is 3.16% of Operating Income.
The Net Earning history of CSTL is 5.49% of Total Revenues.
Per Share Earnings over the last 8 years have been positive in 4 years.

Castle Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Health Care Providers & Services
Sector:	Health Care
Current Symbol:	CSTL
CUSIP:	14843C
Website:	castlebiosciences.com

Debt

Debt-to-Equity Ratio:	0.08
Current Ratio:	6.47
Quick Ratio:	6.09

Price-to-Earnings

Trailing P/E Ratio:	61.96
Forward P/E Ratio:	0

CSTL Technical Analysis vs Fundamental Analysis

Buy

Castle Biosciences, Inc. (CSTL) is a Buy

Is Castle Biosciences, Inc. a Buy or a Sell?

Castle Biosciences, Inc. stock is rated a Buy

The current Castle Biosciences, Inc. [CSTL] share price is $38.64. The Score for CSTL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.